ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 130  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      MT695836 Miniopterus fuliginosus isolate N21333 D-loop, partial sequence; mitochondrial. 294 DNA Miniopterus fuliginosus
      N21333 yx49e10.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:265098 3' similar to gb:K00558 TUBULIN ALPHA-1 CHAIN (HUMAN), mRNA sequence. 468 mRNA Homo sapiens
      LV567155 JP 2017029159-A/21333: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      HW856557 JP 2015051004-A/21285: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      LF680554 JP 2016521556-A/21333: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION. 15 DNA Homo sapiens
      DL903077 JP 2014205669-A/21333: Method of constructing and screening libraries of peptide structures. 21 PRT synthetic construct
      DD801603 JP 2008525033-A/21333: Group B Streptococcus. 687 PRT Streptococcus agalactiae
      MD753575 JP 2019507579-A/21333: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY. 20 DNA synthetic construct
      MC773443 JP 2018525446-A/21333: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF. 28 PRT synthetic construct
      DJ150713 JP 2007228956-A/21331: Method for identification of useful proteins derived from brewery yeast. 25 DNA Saccharomyces pastorianus
      HZ526114 JP 2016501039-A/21333: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      FU795814 JP 2009528046-A/21331: Method for identifying useful proteins of brewery yeast. 25 DNA Saccharomyces pastorianus
      DM722478 JP 2016500250-A/21333: ENGINEERED SECRETED PROTEINS AND METHODS. 120 PRT Saccharomyces cerevisiae
      DJ525133 JP 2010517930-A/21333: Method of constructing and screening libraries of peptide structures. 21 PRT synthetic construct
      DL030347 JP 2005512499-A/21333: Diagnosis of existing illnesses or that praedisposition for determined illnesses. 671 DNA synthetic construct
      PA525817 JP 2022502046-A/8599: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY. 21 DNA synthetic construct
      DD547936 JP 2004508801-A/21333: NEISSERIAL ANTIGENIC PEPTIDES. 6 PRT Neisseria
      DL611935 JP 2011092200-A/21333: NEISSERIAL ANTIGENIC PEPTIDES. 6 PRT Neisseria
      LX118949 JP 2017506877-A/21331: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes. 16 DNA synthetic construct
      HW186361 JP 2013102767-A/21285: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      PA392056 JP 2021533803-A/21139: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE. 26 DNA Homo sapiens
      DM758027 JP 2014079248-A/21333: NEISSERIAL ANTIGENIC PEPTIDES. 6 PRT Neisseria
      MC163177 JP 2019500349-A/21333: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES. 18 RNA synthetic construct
      OG750852 JP 2021120380-A/21333: CANCER NEOEPITOPES. 9 PRT Homo sapiens
      MD267466 JP 2020517247-A/21333: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof. 20 DNA synthetic construct
      LF828489 JP 2016528161-A/21322: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS. 18 RNA synthetic construct
      HV877874 JP 2010507387-A/21285: Novel siRNAs and Methods of Use Thereof. 21 RNA synthetic construct
      PA336981 JP 2021522188-A/21333: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation. 20 DNA synthetic construct
      MC549833 JP 2019525738-A/21333: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES. 8 PRT synthetic construct
      DM795791 JP 2014068652-A/21333: NEISSERIAL ANTIGENIC PEPTIDES. 6 PRT Neisseria
      Now loading
      PAGE TOP